Global Respiratory Inhalers Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12248441

Publication Date:

December 13, 2024

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Respiratory Inhalers market size was valued at US$ 28170 million in 2023. With growing demand in downstream market, the Respiratory Inhalers is forecast to a readjusted size of US$ 31050 million by 2030 with a CAGR of 1.4% during review period.
The research report highlights the growth potential of the global Respiratory Inhalers market. Respiratory Inhalers are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Respiratory Inhalers. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Respiratory Inhalers market.
Respiratory disorders have always been a huge challenge for the drug manufacturers and the medical practitioners. In the last couple of decades, this respiratory disorder prevalence has increased tremendously due to some of the reasons such as air pollution, smoking, industrialization among others. To counter these respiratory disorders, scientists have developed various drugs and devices. Extensive efforts have been made to control the disorders such as Asthma and Chronic obstructive pulmonary disorder which affects the majority of the patients.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Key Features:
The report on Respiratory Inhalers market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Respiratory Inhalers market. It may include historical data, market segmentation by Type (e.g., Dry Powder Inhaler, Metered Dose Inhaler), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Respiratory Inhalers market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Respiratory Inhalers market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Respiratory Inhalers industry. This include advancements in Respiratory Inhalers technology, Respiratory Inhalers new entrants, Respiratory Inhalers new investment, and other innovations that are shaping the future of Respiratory Inhalers.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Respiratory Inhalers market. It includes factors influencing customer ' purchasing decisions, preferences for Respiratory Inhalers product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Respiratory Inhalers market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Respiratory Inhalers market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Respiratory Inhalers market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Respiratory Inhalers industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Respiratory Inhalers market.
Market Segmentation:
Respiratory Inhalers market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Dry Powder Inhaler
Metered Dose Inhaler
Others
Segmentation by application
Asthma
COPD
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Adherium limited
AstraZeneca
Boehringer Ingelheim GmbH
Chiesi Farmaceutici S.p.A.
GSK plc.
Propeller Health
Teva Pharmaceutical Industries Ltd.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Respiratory Inhalers Market Size 2019-2030
2.1.2 Respiratory Inhalers Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Respiratory Inhalers Segment by Type
2.2.1 Dry Powder Inhaler
2.2.2 Metered Dose Inhaler
2.2.3 Others
2.3 Respiratory Inhalers Market Size by Type
2.3.1 Respiratory Inhalers Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Respiratory Inhalers Market Size Market Share by Type (2019-2024)
2.4 Respiratory Inhalers Segment by Application
2.4.1 Asthma
2.4.2 COPD
2.4.3 Other
2.5 Respiratory Inhalers Market Size by Application
2.5.1 Respiratory Inhalers Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Respiratory Inhalers Market Size Market Share by Application (2019-2024)
3 Respiratory Inhalers Market Size by Player
3.1 Respiratory Inhalers Market Size Market Share by Players
3.1.1 Global Respiratory Inhalers Revenue by Players (2019-2024)
3.1.2 Global Respiratory Inhalers Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Inhalers Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Respiratory Inhalers by Regions
4.1 Respiratory Inhalers Market Size by Regions (2019-2024)
4.2 Americas Respiratory Inhalers Market Size Growth (2019-2024)
4.3 APAC Respiratory Inhalers Market Size Growth (2019-2024)
4.4 Europe Respiratory Inhalers Market Size Growth (2019-2024)
4.5 Middle East & Africa Respiratory Inhalers Market Size Growth (2019-2024)
5 Americas
5.1 Americas Respiratory Inhalers Market Size by Country (2019-2024)
5.2 Americas Respiratory Inhalers Market Size by Type (2019-2024)
5.3 Americas Respiratory Inhalers Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Inhalers Market Size by Region (2019-2024)
6.2 APAC Respiratory Inhalers Market Size by Type (2019-2024)
6.3 APAC Respiratory Inhalers Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Respiratory Inhalers by Country (2019-2024)
7.2 Europe Respiratory Inhalers Market Size by Type (2019-2024)
7.3 Europe Respiratory Inhalers Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Respiratory Inhalers by Region (2019-2024)
8.2 Middle East & Africa Respiratory Inhalers Market Size by Type (2019-2024)
8.3 Middle East & Africa Respiratory Inhalers Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Respiratory Inhalers Market Forecast
10.1 Global Respiratory Inhalers Forecast by Regions (2025-2030)
10.1.1 Global Respiratory Inhalers Forecast by Regions (2025-2030)
10.1.2 Americas Respiratory Inhalers Forecast
10.1.3 APAC Respiratory Inhalers Forecast
10.1.4 Europe Respiratory Inhalers Forecast
10.1.5 Middle East & Africa Respiratory Inhalers Forecast
10.2 Americas Respiratory Inhalers Forecast by Country (2025-2030)
10.2.1 United States Respiratory Inhalers Market Forecast
10.2.2 Canada Respiratory Inhalers Market Forecast
10.2.3 Mexico Respiratory Inhalers Market Forecast
10.2.4 Brazil Respiratory Inhalers Market Forecast
10.3 APAC Respiratory Inhalers Forecast by Region (2025-2030)
10.3.1 China Respiratory Inhalers Market Forecast
10.3.2 Japan Respiratory Inhalers Market Forecast
10.3.3 Korea Respiratory Inhalers Market Forecast
10.3.4 Southeast Asia Respiratory Inhalers Market Forecast
10.3.5 India Respiratory Inhalers Market Forecast
10.3.6 Australia Respiratory Inhalers Market Forecast
10.4 Europe Respiratory Inhalers Forecast by Country (2025-2030)
10.4.1 Germany Respiratory Inhalers Market Forecast
10.4.2 France Respiratory Inhalers Market Forecast
10.4.3 UK Respiratory Inhalers Market Forecast
10.4.4 Italy Respiratory Inhalers Market Forecast
10.4.5 Russia Respiratory Inhalers Market Forecast
10.5 Middle East & Africa Respiratory Inhalers Forecast by Region (2025-2030)
10.5.1 Egypt Respiratory Inhalers Market Forecast
10.5.2 South Africa Respiratory Inhalers Market Forecast
10.5.3 Israel Respiratory Inhalers Market Forecast
10.5.4 Turkey Respiratory Inhalers Market Forecast
10.5.5 GCC Countries Respiratory Inhalers Market Forecast
10.6 Global Respiratory Inhalers Forecast by Type (2025-2030)
10.7 Global Respiratory Inhalers Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Adherium limited
11.1.1 Adherium limited Company Information
11.1.2 Adherium limited Respiratory Inhalers Product Offered
11.1.3 Adherium limited Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Adherium limited Main Business Overview
11.1.5 Adherium limited Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Respiratory Inhalers Product Offered
11.2.3 AstraZeneca Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Information
11.3.2 Boehringer Ingelheim GmbH Respiratory Inhalers Product Offered
11.3.3 Boehringer Ingelheim GmbH Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Boehringer Ingelheim GmbH Main Business Overview
11.3.5 Boehringer Ingelheim GmbH Latest Developments
11.4 Chiesi Farmaceutici S.p.A.
11.4.1 Chiesi Farmaceutici S.p.A. Company Information
11.4.2 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Product Offered
11.4.3 Chiesi Farmaceutici S.p.A. Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Chiesi Farmaceutici S.p.A. Main Business Overview
11.4.5 Chiesi Farmaceutici S.p.A. Latest Developments
11.5 GSK plc.
11.5.1 GSK plc. Company Information
11.5.2 GSK plc. Respiratory Inhalers Product Offered
11.5.3 GSK plc. Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GSK plc. Main Business Overview
11.5.5 GSK plc. Latest Developments
11.6 Propeller Health
11.6.1 Propeller Health Company Information
11.6.2 Propeller Health Respiratory Inhalers Product Offered
11.6.3 Propeller Health Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Propeller Health Main Business Overview
11.6.5 Propeller Health Latest Developments
11.7 Teva Pharmaceutical Industries Ltd.
11.7.1 Teva Pharmaceutical Industries Ltd. Company Information
11.7.2 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Product Offered
11.7.3 Teva Pharmaceutical Industries Ltd. Respiratory Inhalers Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.7.5 Teva Pharmaceutical Industries Ltd. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂